Eshelman Ventures
Eshelman Ventures, based in New Castle, provides investment to private healthcare companies.
Business Model:
Revenue: $29.6M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Eshelman Ventures Information
Geographic Data
Address: 319 N 3rd St
City: Wilmington
State: NC
Zip: 28401
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Eshelman Ventures primarily invests in private healthcare companies.
Contact Phone:
+19105586885
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2015 | Innocrin Pharmaceuticals | Series D | 28M |
| 4/2018 | Kinnate Biopharma | Series A | 22M |
| 7/2016 | Sapience Therapeutics | Series A | 0 |
| 6/2015 | Cellective BioTherapy | Angel Round | 2.5M |
| 2/2015 | Dignify Therapeutics | Venture Round | 3M |
| 3/2022 | Incyclix Bio | Series B | 0 |
| 5/2022 | Sapience Therapeutics | Series B | 0 |
| 8/2015 | Carbon | Series C | 100M |
| 5/2016 | G1 Therapeutics | Series C | 0 |
| 7/2019 | Aruna Biomedical | Venture Round | 13M |
| 1/2022 | Aravive Biologics | Post-IPO Equity | 10M |
| 8/2020 | Incyclix Bio | Venture Round | 0 |
| 12/2019 | Liquidia Technologies | Post-IPO Equity | 0 |
| 2/2015 | G1 Therapeutics | Series B | 0 |
| 12/2019 | Kinnate Biopharma | Series B | 74.5M |
| 5/2022 | Sapience Therapeutics | Series B | 0 |
| 3/2022 | Incyclix Bio | Series B | 0 |
| 1/2022 | Aravive Biologics | Post-IPO Equity | 0 |
| 8/2020 | Incyclix Bio | Venture Round | 0 |
| 12/2019 | Liquidia Technologies | Post-IPO Equity | 0 |
| 12/2019 | Kinnate Biopharma | Series B | 0 |
| 7/2019 | Aruna Biomedical | Venture Round | 0 |
| 4/2018 | Kinnate Biopharma | Series A | 0 |
| 7/2016 | Sapience Therapeutics | Series A | 0 |
| 5/2016 | G1 Therapeutics | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
